Dexcom is still accepting orders for products and supplies at this time and does not currently anticipate any interruptions to our ability to produce and supply product, as a result of the coronavirus. However, to ensure supply continuity for all customers, we won’t be processing additional orders for supplies outside of what is covered by a patient’s insurance at this time.

At Dexcom, we consider patient safety our number one priority. With the recent news of the impact COVID-19 is having across the US, we are aligned with community actions that will prevent the spread of the virus and have made the decision to have our field-based employees work from home. We will only allow our employees to enter your facility once it is determined safe to do so. In the meantime, diabetes will continue, and we want to make sure that you have all of the information you need to treat this at-risk population successfully. Our field and all supporting partners will be available via email, telephone, and video meetings to help you meet the needs of your patients with diabetes.

No. While the State of California recently issued a stay-at-home order requiring non-essential businesses to close until further notice, the order does not apply to companies performing “essential” services or functions like Dexcom.

Yes. Remote consultations using Dexcom Clarity may still be eligible for reimbursement under billing code 95251. For resources to set up Dexcom Clarity Clinic, please click here.

*The reimbursement information provided is intended to assist you with billing for your services related to continuous glucose monitoring (CGM). It is intended for informational purposes only and is not a guarantee of coverage and payment. Providers are encouraged to contact their local payers with questions related to coverage, coding, and payment.

Yes. Dexcom apps and software will continue to operate without interruption, and the company does not anticipate any outages or delays due to the coronavirus situation. Patients may check the live status of each of our apps and software at status.dexcom.com.

Please click here for patient support and resources.

Dexcom will continue to process re-orders, but we ask that patients only contact the Customer Sales Support and Technical Support teams at 844-607-8398 with urgent requests at this time.

Answers to many common patient questions are available at dexcom.com/answers, and patients can submit web self-service tickets at dexcom.com/contact. Our team will work to expeditiously respond to those inquiries.

The Dexcom CARE team is also still available at dexcom.com/dexcom-care or 877-339-2664 to help patients that are new to Dexcom and need help getting started with their product.

Patients can continue to get their products from the pharmacy or DME providers. Several national pharmacies are offering home delivery services. Please ask your patients to contact their preferred pharmacy or DME provider for options.

A glucometer measures the sugar levels in a patient's blood, while a Continuous Glucose Monitor (CGM) monitors the levels in interstitial fluid, the fluid between cells in your tissues. Traditional glucometers require a consistent supply of test strips for use, whereas Dexcom is an unblinded non-adjunctive CGM.  The traditional method for patients of measuring glucose levels requires a fingerstick using a glucometer (blood glucose meter) which provides a glucose reading at a single point in time. The key difference between Dexcom CGM and a glucometer is that Dexcom CGM provides glucose readings throughout the day and night, including glucose speed and direction arrows that empower wearers with more information for more informed decision making•. Finally, Dexcom CGM is designed with alerts to warn the wearer of glucose highs and lows during critical times like playing, sleeping, or exercising to help wearers catch high and lows before they become critical.  Here is an example of how Dexcom CGM information could impact glucose management decisions:  Glucometer (BGM) READING: 119 

CONTINUOUS GLUCOSE MONITOR (CGM) READING: 119 

*smart devices sold separately. 
(The straight down arrow signal a rapid decline in glucose) 

Comparing cgm vs glucometer accuracy, both provided patients with current and accurate glucose readings. However, based on the Glucometer (BGM) reading of 119, this person is likely to decide that no action is required. But, with a similar glucose level reading on the Dexcom CGM and the straight down arrow, the patient might decide to eat some carbohydrates to avoid having a hypoglycemic event. 

A continuous glucose monitor (CGM) is an FDA-­approved device that provides continuous insight into glucose levels throughout the day and night. CGM also displays information about glucose direction and speed giving users additional information to help with their diabetes management. CGM also provides customizable alerts to warn the wearer of approaching glucose highs and lows. Studies have shown that CGM contributes to a decrease in HbA1c without increasing the risk for hypoglycemia.¹

CPE/CME courses are available for credit at cgmeducation.net. All courses are free online and available on demand.